On June 8, 2026, India’s benchmark stock indices, the Sensex and the Nifty, experienced a partial recovery after early losses, with the Sensex rebounding by 350 points from its day’s low and the Nifty approaching the 24,250 mark. This rebound was primarily driven by value buying, particularly in the pharmaceutical sector, and technical support levels.
**Market Overview**
The Sensex opened lower, reflecting a gap-down opening, and touched an intraday low of 77,146.44. However, it managed to recover, closing at 78,082.08, down 434.41 points or 0.55% from the previous close. Similarly, the Nifty opened weak, reaching a low of 24,126.55, but later reclaimed the 24,250 level, closing at 24,278.65, down 99.45 points or 0.41%. Market breadth was relatively balanced, with 1,764 shares advancing, 1,650 declining, and 167 remaining unchanged.
**Key Factors Behind the Market Rebound**
1. **Value Buying**
After the initial decline, investors engaged in value buying, particularly in mid and small-cap stocks. VK Vijayakumar, Chief Investment Strategist at Geojit Investments Limited, noted that the broader market outperformed due to the absence of significant Foreign Institutional Investor (FII) selling. He highlighted that FIIs were actively purchasing stocks in the mid and small-cap segments, suggesting that this trend of outperformance is likely to continue. Vijayakumar emphasized that stock-specific actions in response to corporate earnings would drive market movements.
2. **Pharmaceutical Sector Performance**
The pharmaceutical sector played a pivotal role in the market’s partial recovery. The Nifty Pharma index rose nearly 2.5%, with Dr. Reddy’s Laboratories emerging as the top gainer, its shares surging over 6%. Cipla and Sun Pharmaceutical Industries also saw gains of approximately 3% and 1.3%, respectively. Nomura reported that the Indian pharmaceuticals market continued to grow at a double-digit rate of 10.1% year-on-year in March, with most companies under its coverage exceeding expectations during the month.
3. **Technical Support Levels**
From a technical standpoint, the Nifty found support at the 24,100 level, which facilitated the upward movement. Analysts observed that the Nifty 50 faced resistance in the 24,400–24,500 zone, where profit booking had emerged. Immediate support was identified near the 24,100–24,000 range. A sustained move above the resistance band could revive bullish momentum, while failure to hold support might lead to further corrective or range-bound movement in the near term. Aakash Shah, Technical Analyst at Choice Broking, provided these insights.
**Conclusion**
The partial recovery of the Sensex and Nifty on June 8, 2026, was driven by strategic value buying, particularly in the pharmaceutical sector, and technical support levels. Investors are advised to monitor these developments closely, as market dynamics can shift rapidly.
This article is AI-generated content. Please verify the information independently before taking any action based on this article.
